Combination of clinically utilized kappa opioid receptor agonist nalfurafine with low-dose naltrexone reduces excessive alcohol drinking in male and female mice

Lignende værker

• Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice
  af: Zhou, Yan, et al.
  Udgivet: (2019)
• Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone
  af: Zhou, Yan, et al.
  Udgivet: (2017)
• V1b receptor antagonist SSR149415 and naltrexone synergistically decrease excessive alcohol drinking in male and female mice
  af: Zhou, Yan, et al.
  Udgivet: (2017)
• mTORC1 pathway is involved in the kappa opioid receptor activation-induced increase in excessive alcohol drinking in mice
  af: Zhou, Yan, et al.
  Udgivet: (2020)
• Blockade of alcohol excessive and “relapse” drinking in male mice by pharmacological cryptochrome (CRY) activation
  af: Zhou, Yan, et al.
  Udgivet: (2021)